AU3355093A - Method of selecting at least one mutation screen, its application to a method for rapid identification of alleles of polymorphous systems and device for implementation thereof - Google Patents

Method of selecting at least one mutation screen, its application to a method for rapid identification of alleles of polymorphous systems and device for implementation thereof Download PDF

Info

Publication number
AU3355093A
AU3355093A AU33550/93A AU3355093A AU3355093A AU 3355093 A AU3355093 A AU 3355093A AU 33550/93 A AU33550/93 A AU 33550/93A AU 3355093 A AU3355093 A AU 3355093A AU 3355093 A AU3355093 A AU 3355093A
Authority
AU
Australia
Prior art keywords
mutations
alleles
mutation
obligatory
screen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33550/93A
Inventor
Lydie Bougueleret
Daniel Cohen
Nadine Cohen
Jean Dausset
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bertin Technologies SAS
Original Assignee
Bertin et Cie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bertin et Cie SA filed Critical Bertin et Cie SA
Publication of AU3355093A publication Critical patent/AU3355093A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

WO 93/11262 PCT/FR92/01141 Method of selecting at least one mutation screen, its application to a method for the rapid identification of 5 alleles of polymorphous systems and device for implementation thereof. The present invention relates to a method of selecting at least one mutation screen from a set of allelic sequences of a polymorphous gene, to a method for 10 the rapid identification of allelic variations (alleles or allelic sequences) of the sequences of polymorphous genes, to nucleotide probes obtained from the said mutation screens, especially placed in the form of data banks, as well as to a device for implementing the said 15 methods. The present invention also relates to a kit for the identification of the alleles of polymorphous genes. At present, it is very difficult and very tedious to identify the different alleles of the same gene, 20 differing by mutation of at least one base in their nucleotide sequence, especially in the case of naturally polyallelic systems, such as the major histocompatibility system (HLA) whose genes can exist in numerous allelic forms, as well as in any other form of polymorphism, 25 especially those due to somatic mutations such as those of immunoglobulins and T cell receptors or alternatively those encountered in systems equivalent to a polyallelic system, which are more particularly observed in certain multiple-mutation genetic diseases such as cystic 30 fibrosis or Duchenne's muscular dystrophy. The major histocompatibility complex (HLA complex) genes, for example, are closely linked on the short arm of chromosome 6 and extend over about 5000 kb; they encode three types of proteins, the class I, II and 35 III proteins; a major characteristic of the HLA system is its vast polymorphism. The polymorphism of this system results from the number of genes and the number of different alleles which are possible for each of these - 2 genes, the polymorphism being further increased if the fact that an individual may have received the same allele from both its parents (homozygous state) or may have received two different alleles (heterozygous state) is 5 taken into account. Furthermore, if it is considered that for the HLA complex, there may be from 10 to 100 alleles per gene and that 15 to 20 genes encoding the proteins of the HLA complex have currently been characterized, it is 10 practically impossible to carry out a complete typing (or identification) of this complex with the methods currently available, whereas the latter may prove crucial, especially in transplantation. Indeed, the typing of the different polymorphous 15 systems can be currently performed either by immunochemical methods or by DNA/DNA hybridization techniques; however, these techniques have the disadvantage: - of not being sufficiently discriminatory, and 20 therefore of not permitting the differentiation of alleles of very similar structures and - of necessitating the use of a large number of oligonucleotide probes (for example: about 50-60 probes in the case of the DRB gene of the HLA system (see 25 especially the nomenclature of the factors of the HLA system, published in 1990 in Immunogenetics, 31, 131 140), which comprises 56 alleles), and this, insofar as in the molecular biology-based conventional typing methods of the prior art, it is effectively necessary to 30 provide of the order of one probe per allele in order to be able to interpret the result. Now, this identification is often necessary either for preventive reasons, or for curative reasons (especially therapy, surgery, transplants); more par 35 ticularly in the case of the HLA complex, the control of a reliable typing system is made necessary for a preventive purpose by the existence of a correlation between the susceptibility to certain diseases and the - 3 frequency of certain HLA alleles; and for a curative purpose by the necessity to have an HLA compatibility between donor and recipient, in the case of a transplant, as specified above and for the purpose of identifying 5 individuals (especially criminology and search for paternity). Consequently, the Applicant set itself the objective of providing a method for rapid and reliable identification of alleles, which has the advantage of 10 permitting the identification of the complete allelic map of a subject, and this without necessitating the use of a large number of oligonucleotide probes (difficulty of production and high cost of the said probes). The subject of the present invention is a method 15 for the selection, from a series of allelic sequences of a polymorphous gene, of at least one mutation screen intended to specify at least one nucleotide probe suitable for use in differentiating all the alleles, characterized in that it comprises the following steps: 20 (a) selecting all or part of a known consensus sequence of the said polymorphous gene; (b) creating a mutation matrix for the corresponding sequences of known alleles; (c) identifying indiscernible sequences by 25 comparison in twos (alleles having the same mutation profile in the sequence selected in (a)) and excluding one of the members of the said pairs; (e) identifying and counting the obligatory mutations or so-called allele marker mutations, that is 30 to say those which are necessary and adqueate for distinguishing between two alleles which are otherwise identical (set 0 of obligatory mutations); and (f) obtaining the said minimum mutation screen(s), comprising at least the obligatory mutations 35 of step (e). According to an advantageous embodiment of the said method, prior to step (e) for identification and counting of the obligatory mutations, the said method -4 comprises: (d) identifying similar mutations in each of the said sequences of alleles of step (b), so as to treat in the next steps only the mutations which are non-redundant 5 and which constitute the set U of useful mutations; which step (d) is followed by the steps (e) and (f) modified as follows: (e) identifying and counting the obligatory mutations or so-called allele marker mutations, among the 10 useful mutations of the set U, that is to say those which are necessary and adequate for distinguishing between two alleles which are otherwise identical (set 0' of obligatory mutations); and (f) if the obligatory mutations of step (e) do 15 not permit mutation screens suitable for the univocal differentiation of all the alleles to be directly obtained, a minimum number of useful mutations of step (d) (subset Ui derived from the set U of useful mutations) is selected, which mutations, associated with 20 the obligatory mutations of step (e), form the mutation screen(s) suitable for the univocal differentiation of all the alleles. According to an advantageous arrangement of this embodiment, prior to step (f), the said method comprises 25 a step (x) for selecting useful mutations of step (d) (subset U 2 derived from the set U of useful mutations), in order to form a group of useful mutations most suitable for preparing oligonucleotide probes suitable for use in differentiating all the alleles; which step 30 (x) is followed by the step (f) modified as follows: (f) if the obligatory mutations do not permit the direct selection of mutation screens suitable for the univocal differentiation of all the alleles, a minimum number of useful mutations of step (x) is selected, which 35 mutations, associated with the obligatory mutations of step (e), form the mutation screen(s) suitable for the univocal differentiation of all the alleles. Such mutation screens are particularly - 5 advantageous for the selection and preparation of a limited number of oligonucleotide probes suitable for use in differentiating all the alleles of a polymorphous gene. 5 The subject of the present invention is also a method for the identification of alleles (or allelic sequences) of a polymorphous gene, characterized in that it comprises the following steps: I - selecting at least one mutation screen pre 10 pared from a series of allelic sequences of a poly morphous gene in the steps: . (a) to (f ) of the method of selecting at least one mutation screen as defined above (including the different variants); then 15 . (g) choosing, from the screens selected in step (f) of the said mutation screen selection process, the most suitable mutation screen for selecting and preparing oligonucleotide probes suitable for use in differentiating all the alleles; 20 II - actual typing of an allele X to be identified by: (h) appropriately hybridizing the said allele X with the oligonucleotide probes selected from the mutation screen(s) obtained in steps (a) to (g); and 25 (i) identifying the allele X by detection of the said hybrid(s) which may have been formed in step (h). Advantageously, when the mutation screen selec tion process comprises step (d) as defined above, the said step (d) has the advantage of bringing about a first 30 reduction in the mutations to be considered in the subsequent steps, by eliminating a first subset of mutations (redundant mutations) and therefore of con stituting a set U of mutations useful for the charac terization of an allele. 35 The steps (e) to (g) have the advantage: - of permitting the selection of a subset of obligatory mutations, among the useful mutations of the set U which, optionally in association with: - 6 - either a subset U 1 , derived from the set U of useful mutations (the set Ui corresponding to a minimum number of useful mutations which, in association with the obligatory mutations, form mutation screens suitable for 5 the univocal differentiation of all the alleles) - or a subset U 2 , derived from the set U of useful mutations and selected in order to form a group of useful mutations more suitable for preparing appropriate oligonucleotide probes, form mutation screens suitable 10 for the univocal differentiation of all the alleles; and - of permitting, because of the selection of the specific oligonucleotide probes, a rapid identification of the unknown allele. Indeed, the method conforming to the invention 15 permits, in addition to the selection of a limited number of oligonucleotide probes, the selection of probes having the following advantageous characteristics: - maximum pairing with the consensus sequence; - absence of formation of sequences giving rise 20 to the formation of non-specific homo- or heterodimers; - high content of GC bases; and - absence of polypurine or polypyrimidine repeti tive sequences. Furthermore, the method conforming to the 25 invention permits the direct identification of homozygous doublets and their differentiation from heterozygous doublets. In this latter case, in order to obtain, in fine, the mutation screen, the same method as described above 30 is used comprising the analysis of each sequence of the doublet at each position; it is therefore the doublets of alleles which are compared with all the other doublets of alleles. The preventive and curative implications of the 35 precise knowledge of the alleles carried by a given subject are important; the method conforming to the invention makes it possible, in a very short time, to solve this problem.
- 7 The subject of the present invention is also the application of the method for the selection of at least one mutation screen from a series of allelic sequences of a polymorphous gene, to the preparation of a data bank 5 consisting of a series of mutation screens obtained by the above method and intended for the preparation of oligonucleotide probes suitable for use in differentiating all the alleles. The subject of the present invention is also 10 oligonucleotide probes, characterized in that they are constructed for the use of at least one mutation screen derived from the method of selection of at least one mutation screen from a series of allelic sequences of a polymorphous gene or from the data bank as defined above, 15 in that they comprise between 15 and 50 bases and in that they are the most suitable for hybridizing with an allelic sequence for the identification of alleles of a polymorphous gene. Such probes can be optionally labelled by means 20 of a marker such as a radioactive isotope, an appropriate enzyme, a fluorochrome, an antibody or a base analogue; such probes can also be constructed for use in the method for detecting and/or identifying a specific nucleotide base present in a nucleic acid sequence (mutation) 25 described in European Patent Application 412 883, in the Applicant's name. According to an advantageous embodiment of the said probes, they comprise a sequence derived from the selected consensus sequence and whose nucleotide base 30 situated at the 3' end corresponds to a base upstream of one of the mutant bases of the selected mutation screen. The subject of the present invention is also a kit for the identification of alleles of a polymorphous gene, characterized in that it comprises at least: 35 - appropriate quantities of a collection of oligonucleotide probes conforming to the invention; optionally associated with: - appropriate quantities of a reagent for - 8 detection of the probe-sequence to be identified hybrids possibly formed; and/or with - a table for interpretation of the result of the hybridizations obtained, as a function of the selected 5 mutation screen. According to an advantageous embodiment of the said kit, the said probes comprise a sequence derived from the selected consensus sequence and whose nucleotide base situated at the 3' end corresponds to a base 10 upstream of one of the mutant bases of the selected mutation screen. According to another advantageous embodiment of the said kit, it additionally comprises: - appropriate quantities of four nucleotide bases 15 modified so as to be incorporable into the product of extension of the said probes used as primers, while blocking the elongation of the said extension product. Such an embodiment permits the use of the method described in European Patent Application 412 883 in the 20 Applicant's name. The subject of the present invention is, in addition, a device for implementing the method conforming to the invention, characterized in that it comprises at least: 25 - means for input of data, - means for programmed calculation in order to generate the mutation screen(s), - means for storing the said screens, and - means capable of permitting the identification 30 of the alleles from the stored screens. In addition to the preceding arrangements, the invention also comprises other arrangements which will become apparent from the following description, which refers to exemplary embodiments of the method which is 35 the subject of the present invention as well as to the accompanying drawing, in which: - Figure 1 illustrates an embodiment of the method of selecting a mutation screen in which the said - 9 screen is directly obtained from the set 0 of obligatory mutations; - Figure 2 illustrates another embodiment in which the said screen is obtained from a set 0' of 5 obligatory mutations derived from a set U of useful mutations, which set 0' is optionally associated with a subset U 1 or with a subset U 2 of useful mutations, as defined above; - Figure 3 illustrates a device for implementing 10 the methods conforming to the invention (creation phase and exploitation phase); - Figure 4 illustrates a mutation matrix for a sequence of 7 alleles, called All; - Figure 5 illustrates the set U (useful 15 mutations) for identifying a pair of homozygous alleles of the All sequence; - Figure 6 illustrates the mutation screens suitable for the univocal identification of all the pairs of homozygous alleles of All; 20 - Figure 7 illustrates the set U (useful mutations) for identifying a pair of heterozygous alleles of the All gene; - Figure 8 illustrates the mutation screen suitable for the univocal identification of all the 25 doublets of heterozygous alleles of All; - Figure 9 illustrates the set U (useful mutations) for identifying a pair of homozygous alleles of the DQB 1 gene; and - Figure 10 illustrates the set of mutation 30 screens suitable for the identification of all the pairs of homozygous alleles of the DQB 1 gene. It should be understood, however, that these examples are given solely by way of illustration of the subject of the invention and do not constitute in any 35 manner a limitation thereof. A device conforming to the invention permits the implementation of the methods of selection and identification as defined above both in the creation - 10 phase (constitution of the screens) and in the exploit ation phase (identification of an allele). In the creation phase, the mutation matrix for alleles is introduced in (1) into an appropriate 5 microprocessor (A) and generates in (4), by means of the method for selecting at least one mutation screen conforming to the invention, a set of screens, which are stored in (3, 3') in a data bank. In the exploitation phase, a sequence to be 10 identified is hybridized with a collection of suitable probes, constructed for the use of at least one mutation screen; from the hybrids obtained, the sequence is identified (experimental data introduced in (2)); the result obtained is compared with the screen in (5), which 15 makes it possible to specify the allele in question. EXAMPLE 1: Constitution of mutation screens for the homozygous alleles of the All gene. . the sequence All*0501 is selected as consensus sequence as seen in Figure 4, in which the first sequence 20 is considered as consensus sequence; in the other sequences, only the mutations with respect to the said consensus sequence are indicated. . the alleles are compared in twos and the mutations useful for differentiating each pair of alleles 25 are identified: the useful mutations found with the method conforming to the invention are 9 in number: 5, 8, 14, 19, 20, 21, 36, 48, 49 in conformity with Figure 5. In this example, a pair of alleles is indiscernible (pair 30 All*0201 and All*0202); the allele All*0202 is consequently suppressed for the rest of the analysis. . the search for the obligatory mutations is then carried out: All*0401 and All*0501 differ by only 36. 35 It emerges from this research that only one obligatory position exists among the useful mutations, it is position 36. . in the present case, the only obligatory - 11 mutation does not permit all the possible pairs of alleles to be differentiated; no "solutions" exist, that is to say screens which permit the univocal identification of all the alleles considered, with a 5 number of mutations of less than 3 (that is to say 2 additional mutations) . All the possible mutation screens with 3 mutations are: 1) 36, 5, 20 2) 36, 8, 20 10 3) 36, 14, 20, in conformity with Figures 6.1 to 6.3 and show that it is possible to identify an allele of the All gene with the aid of any one of these mutation screens. EXAMPLE 2: Constitution of mutation screens for the 15 heterozygous alleles of the All gene. In this example, after execution of the steps as described in Example 1, and which result in the identification of the useful mutations as seen in Figure 7, the search is carried out for the obligatory mutations 20 which permit differentiation of all the doublets of alleles: All*0401, All*0401 and All*0501, All*0401 differ by only 36; All*0401, All*0401 and All*0501, All*0501 differ by only 25 36; All*0302, All*0401 and All*0501, All*0302 differ by only 36; All*0301, All*0401 and All*0501, All*0301 differ by only 36; 30 All*0201, All*0401 and All*0501, All*0201 differ by only 36; All*0502, All*0401 and All*0501, All*0502 differ by only 36; All*0501, All*0401 and All*0501, Al1*0501 differ by only 35 36. It emerges from this search that only one obligatory position exists among the useful mutations; it is position 36.
- 12 In this example, this single obligatory mutation does not permit differentiation of all the doublets of alleles. No "solutions" exist with a number less than 3, that is to say 2 additional positions. One of the 5 mutation screens which permits differentiation of all the doublets of alleles is: 36, 5, 20, in conformity with Figure 8. EXAMPLE 3: Typing of an All heterozygous individual. The mutation screen of Example 2 is chosen in 10 order to identify alleles, because it is the most suitable for the preparation of probes which correspond to the selection criteria defined above (maximum pairing with the consensus sequence, absence of sequences giving rise to the formation of homo- or heterodimers, high 15 content of GC bases and absence of polypurine or polypyrimidine repetitive sequences). Probes of 20 oligonucleotides are synthesized such that position 3' of the said probes corresponds to a base situated just upstream of one of the positions of 20 the above screens, such that when the hybridization and extension under the conditions of the abovementioned European Patent Application is carried out, it is possible to verify which of the base(s) hybridize(s). The use of such a panel of probes makes it possible to 25 identify . in individual 1, the sequence CC CT CC which, with reference to the chosen screen, makes it possible to identify the pair of alleles All*0201, All*0302, and . in the tested individual 2, the sequence CC CT 30 CG which, with reference to the chosen screen, makes it possible to identify the pair of alleles All*0502, All*0201. EXAMPLE 4: Constitution of mutation screens for the homozygous alleles of the HLA-DQB 1 gene 35 The nomenclature of the factors of the HLA system was published in 1990 in Immunogenetics, 31, 131-140 and the following example illustrates the constitution of a mutation screen for the alleles of the HLA-DQB 1 gene, as - 13 defined in this article. . the sequence DQB 1*0501 (position 1 to position 300) is selected as consensus sequence; . the positions of similar mutations are iden 5 tified so that they are considered only once; the following result is obtained: * mutation 25 is similar to 7; * mutation 140 is similar to 110; * mutation 186 is similar to 167; 10 * mutation 266 is similar to 250; * mutation 269 is similar to 259; * mutation 280 is similar to 277; consequently, mutations 25, 140, 186, 266, 269 and 280 are ignored in the next step of the method (the numbers 15 correspond to the positions of the mutations on the sequence). . the alleles are compared in twos and the mutations useful for differentiating each pair of alleles are identified: the useful mutations found with the 20 method conforming to the invention are 54 in number: 7 26 38 40 57 63 68 75 76 77 81 83 88 89 105 109 110 113 114 134 137 141 144 147 153 155 158 164 167 169 170 171 198 199 208 209 211 212 213 216 220 221 223 230 231 234 250 253 257 259 260 265 271 277, in conformity with 25 Figure 9. In this example, all the pairs of alleles can be differentiated. . the search for the obligatory mutations is then carried out: 30 DQB 1*0402 and DQB 1*0401 differ by only 68, DQB 1*03032 and DQB 1*03031 differ by only 63, DQB 1*03032 and DQB 1*0302 differ by only 170. It emerges from this search that the obligatory positions among the useful mutations are 63, 68 and 170. 35 . in the present case, the three obligatory mutations do not permit differentiation of all the possible pairs of alleles; no solutions exist with a number of mutations of less than 7 (that is to say 4 - 14 additional mutations). All the possible mutation screens with 7 mutations are: 1- 63, 68, 170, 7, 76, 88, 171 2- 63, 68, 170, 7, 77, 88, 171 5 3- 63, 68, 170, 26, 76, 88, 171, 4- 63, 68, 170, 26, 76, 88, 231, 5- 63, 68, 170, 26, 77, 88, 171, 6- 63, 68, 170, 26, 77, 88, 231, 7- 63, 68, 170, 57, 76, 88, 171, 10 8- 63, 68, 170, 57, 77, 88, 171, 9- 63, 68, 170, 76, 88, 109, 171, 10- 63, 68, 170, 76, 88, 113, 171, 11- 63, 68, 170, 76, 88, 114, 171, 12- 63, 68, 170, 76, 88, 114, 231, 15 13- 63, 68, 170, 76, 88, 134, 171, 14- 63, 68, 170, 76, 88, 141, 171, 15- 63, 68, 170, 76, 88, 141, 231, 16- 63, 68, 170, 76, 88, 153, 171, 17- 63, 68, 170, 76, 88, 158, 171, 20 18- 63, 68, 170, 76, 88, 158, 231, 19- 63, 68, 170, 76, 88, 164, 171, and 20- 63, 68, 170, 76, 88, 164, 231, in conformity with Figures 10.1 to 10.20 (in which the 25 allele DQB 1 is represented by DQBB1) and show that it is possible to identify an allele of the DQB 1 gene with the aid of any one of these mutation screens. As evident from the above, the invention is not in any way limited to those of its embodiments, 30 implementations and applications which have just been described more explicity; it embraces, on the contrary, all the variants which may occur to the specialist in this field, without departing from the framework or the scope of the present invention.

Claims (11)

1. Method for the selection, from a series of allelic sequences of a polymorphous gene, of at least one 5 mutation screen intended to specify at least one nucleotide probe suitable for use in differentiating all the alleles, characterized in that it comprises the following steps: (a) selecting all or part of a known consensus 10 sequence of the said polymorphous gene; (b) creating a mutation matrix for the corresponding sequences of known alleles; (c) identifying indiscernible sequences by comparison in twos (alleles having the same mutation 15 profile in the sequence selected in (a)) and excluding one of the members of the said pairs; (e) identifying and counting the obligatory mutations or so-called allele marker mutations, that is to say those which are necessary and adqueate for 20 distinguishing between two alleles which are otherwise identical (set 0 of obligatory mutations); and (f) obtaining the said minimum mutation screen(s), comprising at least the obligatory mutations of step (e). 25
2. Method of selection according to Claim 1, characterized in that, prior to step (e) for identification and counting of the obligatory mutations, the said method comprises: (d) identifying similar mutations in each of the 30 said sequences of alleles of step (b), so as to treat in the next steps only the mutations which are non-redundant and which constitute the set U of useful mutations; which step (d) is followed by the steps (e) and (f) modified as follows: 35 (e) identifying and counting the obligatory mutations or so-called allele marker mutations, among the useful mutations of the set U, that is to say those which are necessary and adequate for distinguishing between two - 16 alleles which are otherwise identical (set 0' of obligatory mutations); and (f) if the obligatory mutations of step (e) do not permit mutation screens suitable for the univocal 5 differentiation of all the alleles to be directly obtained, a minimum number of useful mutations of step (d) (subset U 1 derived from the set U of useful mutations) is selected, which mutations, associated with the obligatory mutations of step (e), form the mutation 10 screen(s) suitable for the univocal differentiation of all the alleles.
3. Method of selection according to Claim 2, characterized in that, prior to step (f), the said method comprises a step (x) for selecting useful mutations of 15 step (d) (subset U 2 derived from the set U of useful mutations), in order to form a group of useful mutations most suitable for preparing oligonucleotide probes suitable for use in differentiating all the alleles; which step (x) is followed by the step (f) modified as 20 follows: (f) if the obligatory mutations do not permit the direct selection of mutation screens suitable for the univocal differentiation of all the alleles, a minimum number of useful mutations of step (x) is selected, which 25 mutations, associated with the obligatory mutations of step (e), form the mutation screen(s) suitable for the univocal differentiation of all the alleles.
4. Method for the identification of alleles of a polymorphous gene, characterized in that it comprises the 30 following steps: I - selecting at least one mutation screen pre pared from a series of allelic sequences of a polymorphous gene in the steps: . (a) to (f) of the method of selection according 35 to any one of Claims 1 to 3; then . (g) choosing, from the screens selected in step (f) of the said mutation screen selection process, the most suitable mutation screen for preparing - 17 oligonucleotide probes suitable for use in differentiating all the alleles; II - actual typing of an allele X to be identified by: 5 (h) appropriately hybridizing the said allele X with the oligonucleotide probes selected from the mutation screen(s) obtained in steps (a) to (g); and (i) identifying the allele X by detection of the said hybrid(s) which may have been formed in step (h). 10
5. Application of the method according to any one of Claims 1 to 3, to the preparation of a data bank consisting of a series of mutation screens obtained by the above method and intended for the preparation of oligonucleotide probes suitable for use in differen 15 tiating all the alleles.
6. Oligonucleotide probes, characterized in that they are constructed for the use of at least one mutation screen derived from the method of selection according to any one of Claims 1 to 3 or from the data bank prepared 20 according to Claim 5, in that they comprise between 15 and 50 bases and in that they are the most suitable for hybridizing with an allelic sequence for the identification of alleles of a polymorphous gene.
7. Probes according to Claim 6, characterized in 25 that they comprise a sequence derived from the selected consensus sequence and whose nucleotide base situated at the 3' end corresponds to a base upstream of one of the mutant bases of the selected mutation screen.
8. Kit for the identification of alleles of a 30 polymorphous gene, characterized in that it comprises at least: - appropriate quantities of a collection of oligonucleotide probes according to Claim 6 or Claim 7; possibly associated with: 35 - appropriate quantities of a reagent for detection of the probe-sequence to be identified hybrids possibly formed; and/or with - a table for interpretation of the result of the - 18 hybridizations obtained, as a function of the selected mutation screen.
9. Kit according to Claim 8, characterized in that the said probes comprise a sequence derived from the selected 5 consensus sequence and whose nucleotide base situated at the 3' end corresponds to a base upstream of one of the mutant bases of the selected mutation screen.
10. Kit according to Claim 8 or Claim 9, characterized in that it additionally comprises: 10 - appropriate quantities of four nucleotide bases modified so as to be incorporable into the product of extension of the said probes used as primers, while blocking the elongation of the said extension product.
11. Device for implementing the methods according to 15 any one of Claims 1 to 4, characterized in that it comprises at least: - means for input of data (1, 2), - means for programmed calculation in order to generate the mutation screen(s) (4), 20 - means for storing the said screens (3, 3'), and - means (5) capable of permitting the iden tification of the alleles from the stored screens.
AU33550/93A 1991-12-04 1992-12-03 Method of selecting at least one mutation screen, its application to a method for rapid identification of alleles of polymorphous systems and device for implementation thereof Abandoned AU3355093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114996 1991-12-04
FR9114996A FR2684688B1 (en) 1991-12-04 1991-12-04 METHOD FOR SELECTING AT LEAST ONE MUTATION SCREEN, ITS APPLICATION TO A PROCESS FOR QUICK IDENTIFICATION OF POLYMORPHIC ALLELES AND DEVICE FOR ITS IMPLEMENTATION.

Publications (1)

Publication Number Publication Date
AU3355093A true AU3355093A (en) 1993-06-28

Family

ID=9419645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33550/93A Abandoned AU3355093A (en) 1991-12-04 1992-12-03 Method of selecting at least one mutation screen, its application to a method for rapid identification of alleles of polymorphous systems and device for implementation thereof

Country Status (6)

Country Link
EP (1) EP0549388A1 (en)
JP (1) JPH07501449A (en)
AU (1) AU3355093A (en)
CA (1) CA2123789A1 (en)
FR (1) FR2684688B1 (en)
WO (1) WO1993011262A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585466B1 (en) 1993-12-23 2009-09-08 Beckman Coulter, Inc. Automatic genotype determination

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762876A (en) * 1991-03-05 1998-06-09 Molecular Tool, Inc. Automatic genotype determination
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103960B1 (en) * 1982-07-30 1991-01-23 Mach, Bernard François, Prof. Dna sequences coding for the dr beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
WO1992010589A1 (en) * 1990-12-06 1992-06-25 F. Hoffmann-La Roche Ag Methods and reagents for hla drbeta dna typing
US6194561B1 (en) * 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
CA1284931C (en) * 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5310893A (en) * 1986-03-31 1994-05-10 Hoffmann-La Roche Inc. Method for HLA DP typing
FR2650840B1 (en) * 1989-08-11 1991-11-29 Bertin & Cie RAPID DETECTION AND / OR IDENTIFICATION OF A SINGLE BASED ON A NUCLEIC ACID SEQUENCE, AND ITS APPLICATIONS
NL9002259A (en) * 1990-10-17 1992-05-18 Eurodiagnostics B V METHOD FOR DETERMINING A GENOTYPE BY COMPARING THE NUCLEOTID SEQUENCE OF MEM FAMILY MEMBERS AND KIT FOR DETECTING GENETIC VARIATIONS.
DE69125368T2 (en) * 1990-12-21 1997-10-09 Hoffmann La Roche CARACTERIZATION OF HLA-DQBETA DNA

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585466B1 (en) 1993-12-23 2009-09-08 Beckman Coulter, Inc. Automatic genotype determination

Also Published As

Publication number Publication date
FR2684688B1 (en) 1994-03-18
CA2123789A1 (en) 1993-06-10
EP0549388A1 (en) 1993-06-30
JPH07501449A (en) 1995-02-16
FR2684688A1 (en) 1993-06-11
WO1993011262A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
Krawczak et al. DNA fingerprinting
DE69920032T2 (en) METHODS, SOFTWARE AND APPARATUS FOR IDENTIFYING GENOMIC AREAS CONTAINING A GENE ASSOCIATED WITH A DETECTABLE CHARACTERISTIC
Murray et al. A comprehensive human linkage map with centimorgan density
US5811235A (en) Method of characterisation
US5633134A (en) Method for simultaneously detecting multiple mutations in a DNA sample
Peterson et al. The distribution of linkage disequilibrium over anonymous genome regions
JP2000504575A (en) Chip-based speciation and phenotypic characterization of microorganisms
EP1954821B1 (en) Method and probes for identifying a nucleotide sequence
US20040023237A1 (en) Methods for genomic analysis
Martin et al. Characterization of 12 microsatellite loci of the human MHC in a panel of reference cell lines
AU3355093A (en) Method of selecting at least one mutation screen, its application to a method for rapid identification of alleles of polymorphous systems and device for implementation thereof
Willard et al. Molecular organization and haplotype analysis of centromeric DNA from human chromosome 17: implications for linkage in neurofibromatosis
EP2186911B1 (en) A method for determining the Histocompatibility Locus Antigen Class II
Del Mastro et al. Human chromosome-specific cDNA libraries: new tools for gene identification and genome annotation.
US20040023275A1 (en) Methods for genomic analysis
Schork et al. A nonmathematical overview of modern gene mapping techniques applied to human diseases
Belmont et al. Genome-wide linkage disequilibrium and haplotype maps
Buetow et al. A microsatellite-based multipoint index map of human chromosome 22
Bartoloni et al. Use of a CEPH meiotic breakpoint panel to refine the locus of limb-girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31
Belmont et al. Complex phenotypes and complex genetics: an introduction to genetic studies of complex traits
US20040029161A1 (en) Methods for genomic analysis
Williams Neuroscience meets quantitative genetics: using morphometric data to map genes that modulate CNS architecture
Jarnik et al. Overall Informativity, OI, in DNA Polymorphisms Revealed by inter-AluPCR: Detection of Genomic Rearrangements
Navidi et al. Analysis of genetic data from the polymerase chain reaction
EP0887423A1 (en) A method for determining the Histocompatibility locus antigen class II